Literature DB >> 17190533

Cardiac tissue Doppler imaging in sports medicine.

Anne Krieg1, Jürgen Scharhag, Wilfried Kindermann, Axel Urhausen.   

Abstract

The differentiation of training-induced cardiac adaptations from pathological conditions is a key issue in sports cardiology. As morphological features do not allow for a clear delineation of early stages of relevant pathologies, the echocardiographic evaluation of left ventricular function is the technique of first choice in this regard. Tissue Doppler imaging (TDI) is a relatively recent method for the assessment of cardiac function that provides direct, local measurements of myocardial velocities throughout the cardiac cycle. Although it has shown a superior sensitivity in the detection of ventricular dysfunction in clinical and experimental studies, its application in sports medicine is still rare. Besides technical factors, this may be due to a lack in consensus on the characteristics of ventricular function in relevant conditions. For more than two decades there has been an ongoing debate on the existence of a supernormal left ventricular function in athlete's heart. While results from traditional echocardiography are conflicting, TDI studies established an improved diastolic function in endurance-trained athletes with athlete's heart compared with controls.The influence of anabolic steroids on cardiac function also has been investigated by standard echocardiographic techniques with inconsistent results. The only TDI study dealing with this topic demonstrated a significantly impaired diastolic function in bodybuilders with long-term abuse of anabolic steroids compared with strength-trained athletes without abuse of anabolic steroids and controls, respectively.Hypertrophic cardiomyopathy is the most frequent cause of sudden death in young athletes. However, in its early stages, it is difficult to distinguish from athlete's heart. By means of TDI, ventricular dysfunction in hypertrophic cardiomyopathy can be disclosed even before the development of left ventricular hypertrophy. Also, a differentiation of left ventricular hypertrophy due to hypertrophic cardiomyopathy or systemic hypertension is possible by TDI. Besides the evaluation of different forms of left ventricular hypertrophy, the diagnosis of myocarditis is also of particular importance in athletes. Today, it still requires myocardial biopsy. The analysis of focal disturbances in myocardial velocities might be a promising non-invasive method; however, systematic validation studies are lacking. An important future issue for the implementation of TDI into routine examination will be the standardisation of procedures and the establishment of significant reference values for the above-mentioned conditions. Innovative TDI parameters also merit further investigation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17190533     DOI: 10.2165/00007256-200737010-00002

Source DB:  PubMed          Journal:  Sports Med        ISSN: 0112-1642            Impact factor:   11.136


  117 in total

1.  Feasibility and reproducibility of off-line tissue Doppler measurement of regional myocardial function during dobutamine stress echocardiography.

Authors:  A G Fraser; N Payne; C F Mädler; B Janerot-Sjøberg; B Lind; R M Grocott-Mason; A A Ionescu; N Florescu; U Wilkenshoff; P Lancellotti; M Wütte; L A Brodin
Journal:  Eur J Echocardiogr       Date:  2003-03

2.  Left ventricular mechanics during exercise: a Doppler and tissue Doppler study.

Authors:  A Stoylen; U Wisløff; S Slørdahl
Journal:  Eur J Echocardiogr       Date:  2003-12

3.  Prognostic value of intra-left ventricular electromechanical asynchrony in patients with hypertrophic cardiomyopathy.

Authors:  Antonello D'Andrea; Pio Caso; Sergio Severino; Sergio Cuomo; Giovanbattista Capozzi; Paolo Calabrò; Gennaro Cice; Luigi Ascione; Marino Scherillo; Raffaele Calabrò
Journal:  Eur Heart J       Date:  2005-12-19       Impact factor: 29.983

4.  Tissue Doppler imaging for the detection and quantitation of myocardial dysfunction in patients with type 2 diabetes mellitus.

Authors:  Helene Von Bibra; Inga S Thrainsdottir; Alexander Hansen; Vasilios Dounis; Klas Malmberg; Lars Rydén
Journal:  Diab Vasc Dis Res       Date:  2005-02       Impact factor: 3.291

5.  The effects of isometric stress on left ventricular filling in athletes with isometric or isotonic training compared to hypertensive and normal controls.

Authors:  E G Abinader; D Sharif; M Sagiv; E Goldhammer
Journal:  Eur Heart J       Date:  1996-03       Impact factor: 29.983

Review 6.  Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (1).

Authors:  B J Maron; R O Bonow; R O Cannon; M B Leon; S E Epstein
Journal:  N Engl J Med       Date:  1987-03-26       Impact factor: 91.245

7.  Quantitative Doppler tissue imaging of the left ventricular myocardium: validation in normal subjects.

Authors:  C L Donovan; W F Armstrong; D S Bach
Journal:  Am Heart J       Date:  1995-07       Impact factor: 4.749

Review 8.  The usefulness of Doppler myocardial imaging in the study of the athlete's heart and in the differential diagnosis between physiological and pathological ventricular hypertrophy.

Authors:  Antonello D'Andrea; Luigi D'Andrea; Pio Caso; Marino Scherillo; Paolo Zeppilli; Raffaele Calabrò
Journal:  Echocardiography       Date:  2006-02       Impact factor: 1.724

9.  Are the cardiac effects of anabolic steroid abuse in strength athletes reversible?

Authors:  A Urhausen; T Albers; W Kindermann
Journal:  Heart       Date:  2004-05       Impact factor: 5.994

10.  Left ventricular wall thickening does occur in elite power athletes with or without anabolic steroid Use.

Authors:  R D Dickerman; F Schaller; W J McConathy
Journal:  Cardiology       Date:  1998-10       Impact factor: 1.869

View more
  10 in total

1.  Maximal oxygen consumption is best predicted by measures of cardiac size rather than function in healthy adults.

Authors:  André La Gerche; Andrew T Burns; Andrew J Taylor; Andrew I Macisaac; Hein Heidbüchel; David L Prior
Journal:  Eur J Appl Physiol       Date:  2011-10-01       Impact factor: 3.078

2.  The upper limit of physiological cardiac hypertrophy in elite male and female athletes in China.

Authors:  Biao Sun; Ji Zheng Ma; Yong Hong Yong; Yuan Yuan Lv
Journal:  Eur J Appl Physiol       Date:  2007-07-28       Impact factor: 3.078

Review 3.  Endurance athletes' stroke volume response to progressive exercise: a critical review.

Authors:  Thomas Rowland
Journal:  Sports Med       Date:  2009       Impact factor: 11.136

Review 4.  Competitive sports and the heart: benefit or risk?

Authors:  Jürgen Scharhag; Herbert Löllgen; Wilfried Kindermann
Journal:  Dtsch Arztebl Int       Date:  2013-01-07       Impact factor: 5.594

Review 5.  Illicit use of androgens and other hormones: recent advances.

Authors:  Gen Kanayama; Harrison G Pope
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2012-06       Impact factor: 3.243

Review 6.  Anabolic steroids and cardiovascular risk.

Authors:  Peter Angell; Neil Chester; Danny Green; John Somauroo; Greg Whyte; Keith George
Journal:  Sports Med       Date:  2012-02-01       Impact factor: 11.136

7.  Cardiovascular health, part 1: preparticipation cardiovascular screening.

Authors:  Sanjaya Gupta; Timir Baman; Sharlene M Day
Journal:  Sports Health       Date:  2009-11       Impact factor: 3.843

8.  The Role of Echocardiography in Evaluation of Athletic Heart: A Scoping Study.

Authors:  Yitzhak Rosen; Hymie H Chera; Mohammed Abdulrazzaq; Mohammed Al-Sadawi; Boaz D Rosen; Joao Lima; Richard Grodman; Jason Lazar; Samy I McFarlane
Journal:  Int J Clin Res Trials       Date:  2020-12-07

9.  Heart and athlete.

Authors:  Mohammad Alasti; Bita Omidvar; Mohammad Hossein Jadbabaei
Journal:  J Tehran Heart Cent       Date:  2010-02-28

10.  Echocardiographic reference intervals with allometric scaling of 823 clinically healthy rhesus macaques (Macaca mulatta).

Authors:  Yu Ueda; Laetitia M M Duler; Kami J Elliot; Paul-Michael D Sosa; Jeffrey A Roberts; Joshua A Stern
Journal:  BMC Vet Res       Date:  2020-09-22       Impact factor: 2.741

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.